Angiotensin (1–7) prevents angiotensin <scp>II</scp>‐induced nociceptive behaviour via inhibition of p38 <scp>MAPK</scp> phosphorylation mediated through spinal <scp>M</scp>as receptors in mice

European Journal of Pain - Tập 18 Số 10 - Trang 1471-1479 - 2014
Wataru Nemoto1, Yoshiki Ogata1, Osamu Nakagawasai1, Fukie Niijima1, Takeshi Tadano2, Koichi Tan–No1
1Department of Pharmacology, Tohoku Pharmaceutical University, Sendai, Japan
2Laboratory of Environmental and Health Sciences, College of Medical Pharmaceutical and Health Sciences, Kanazawa University, Japan

Tóm tắt

AbstractBackgroundWe have recently demonstrated that intrathecal (i.t.) administration of angiotensin II (Ang II) induces nociceptive behaviour in mice accompanied by a phosphorylation of p38 mitogen‐activated protein kinase (MAPK) mediated through Ang II type 1 (AT1) receptors. The N‐terminal fragment of Ang II, Ang (1–7), plays a pivotal role in counterbalancing many of the well‐established actions induced by Ang II. However, the role of Ang (1–7) in spinal nociceptive transmission remains unclear. Therefore, we examined whether i.t. administration of Ang (1–7) can inhibit the Ang II‐induced nociceptive behaviour in mice.MethodsIn the behavioural experiments, the accumulated response time of nociceptive behaviour consisting of scratching, biting and licking in conscious mice was determined during a 25‐min period starting after i.t. injection. The distribution and localization of AT1 or Mas receptors were analysed using a MapAnalyzer and confocal microscope, respectively. Phosphorylation of p38 MAPK in the dorsal spinal cord was measured by Western blotting.ResultsThe nociceptive behaviour induced by Ang II was dose‐dependently inhibited by the co‐administration of Ang (1–7). The inhibitory effect of Ang (1–7) was reversed by the co‐administration of A779, a Mas receptor antagonist. Western blot analysis showed that the increase in spinal p38 MAPK phosphorylation following the i.t. administration of Ang II was also inhibited by Ang (1–7), and the Ang (1–7) induced‐inhibition was prevented by A779.ConclusionsOur data show that the i.t. administration of Ang (1–7) attenuates an Ang II‐induced nociceptive behaviour and is accompanied by the inhibition of p38 MAPK phosphorylation mediated through Mas receptors.

Từ khóa


Tài liệu tham khảo

10.1111/j.1476-5381.2011.01613.x

10.1146/annurev.pharmtox.42.091701.082314

10.1152/ajpheart.00141.2007

10.1152/ajpheart.1995.269.1.H313

10.1371/journal.pmed.0030338

10.1161/01.HYP.30.3.549

10.1186/1744-8069-4-17

Gasparo M., 2000, International union of pharmacology. XXIII. The angiotensin II receptors, Pharmacol Rev, 52, 415

10.1161/01.RES.87.5.e1

10.1152/ajpheart.00618.2005

10.1590/S1807-59322011000500021

10.1016/j.regpep.2012.01.001

10.1016/j.ghir.2012.08.003

10.1016/j.neulet.2007.11.065

10.1016/0014-2999(80)90515-4

10.1161/01.HYP.31.1.356

10.1523/JNEUROSCI.23-10-04017.2003

10.1097/00001756-200212200-00021

10.1161/01.CIR.0000160867.23556.7D

10.1111/j.1469-7580.2009.01058.x

10.1016/j.neuroscience.2008.11.044

10.1152/ajpheart.00832.2011

10.1016/j.regpep.2012.04.001

10.1186/1744-8069-9-38

Ni L., 2012, Angiotensin‐(1–7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways, Oncol Rep, 27, 783

10.1161/01.HYP.0000237862.94083.45

10.1152/physrev.00036.2005

10.1016/j.neuroscience.2004.12.046

10.1016/S0006-8993(03)02541-1

10.1042/BJ20040634

10.1016/S0304-3940(99)00958-1

10.1016/0024-3205(90)90291-X

10.1113/expphysiol.2008.042002

10.1161/01.HYP.0000052947.60363.24

10.1073/pnas.1432869100

10.1038/sj.ki.5001509

10.1097/00001756-200306110-00010

10.1046/j.1471-4159.2003.01969.x

10.1016/j.pain.2004.07.007

10.1016/j.neuroscience.2008.03.041

10.1161/ATVBAHA.110.204453

10.1002/glia.10308

10.1074/jbc.M200581200

10.1016/j.pan.2012.07.017

10.1213/01.ane.0000287660.29297.7b

10.1016/j.regpep.2012.04.002

10.1016/0304-3940(93)90785-J

10.1152/ajprenal.00548.2009